Jump to content

2-Me-DET

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by PrimeBOT (talk | contribs) at 18:03, 9 August 2020 (External links: Task 24 - removal of a template following a TFD (+genfixes)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

2-Me-DET
Names
IUPAC name
Diethyl-[2-(2-methyl-1H-indol-3-yl)-ethyl]-amine
Other names
2-Methyl-diethyltryptamine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C15H22N2/c1-4-17(5-2)11-10-13-12(3)16-15-9-7-6-8-14(13)15/h6-9,16H,4-5,10-11H2,1-3H3 checkY
    Key: VVUATPWGKMGHGM-UHFFFAOYSA-N checkY
  • InChI=1/C15H22N2/c1-4-17(5-2)11-10-13-12(3)16-15-9-7-6-8-14(13)15/h6-9,16H,4-5,10-11H2,1-3H3
    Key: VVUATPWGKMGHGM-UHFFFAOYAW
  • c1cccc2c1c(c([nH]2)C)CCN(CC)CC
Properties
C15H22N2
Molar mass 230.35 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

2-Me-DET, or 2-methyl-diethyltryptamine, is a lesser-known psychedelic drug. It is the 2-methyl analog of DET. 2-Me-DET was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 80-120 mg, and the duration listed as 6–8 hours. 2-Me-DET produces pitch distortion, like that of DiPT. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2-Me-DET.

See also